0001171843-23-006567.txt : 20231031 0001171843-23-006567.hdr.sgml : 20231031 20231031184554 ACCESSION NUMBER: 0001171843-23-006567 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231027 FILED AS OF DATE: 20231031 DATE AS OF CHANGE: 20231031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LALANDE KEVIN M. CENTRAL INDEX KEY: 0001587800 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32979 FILM NUMBER: 231366079 MAIL ADDRESS: STREET 1: 201 WEST 5TH STREET CITY: AUSTIN STATE: TX ZIP: 78701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Molecular Templates, Inc. CENTRAL INDEX KEY: 0001183765 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943409596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 BUSINESS PHONE: 512 896 1555 MAIL ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 FORMER COMPANY: FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020828 4 1 ownership.xml X0508 4 2023-10-27 0 0001183765 Molecular Templates, Inc. MTEM 0001587800 LALANDE KEVIN M. C/O SANTE VENTURES 201 WEST 5TH STREET, SUITE 1500 AUSTIN TX 78701 1 0 1 0 0 Stock Option (right to buy) 6.06 2023-10-27 4 A 0 1000 0.00 A 2033-10-27 Common Stock 1000 1000 D The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on August 11, 2023. The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of October 27, 2023. /s/Kevin M. Lalande 2023-10-31